Form 4 holding
SVP, Chief Medical Officer
SUPERNUS PHARMACEUTICALS, INC.
- Security class
- Restricted Stock Unit
- Shares / value
- 0
- Estimated value
- $97,875
- Report date
- 02 Nov 2026
- Price
- $39.15
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount